Interaction between IL-3 on exosome and IL3R on CML blast  Reverse sensitivity of chemotherapeutic agent (Imatinib) through decreasing BCR-ABL mRNA and protein level. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.